3 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Recruiting 2 |
Follow Nuwiq: new trials by email Literature Review of Nuwiq trials Research Report on Nuwiq
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery Nuwiq - Hemophilia A | Phase 4 | Recruiting | Octapharma | 28 | 2026-04-01 | 2026-05-12 |
| Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study Nuwiq - Severe Hemophilia A | Phase 4 | Recruiting | Octapharma | 28 | 2023-11-28 | 2026-05-12 |
| Treatment of Hemophilia A Patients With FVIII Inhibitors Nuwiq, Octanate, Wilate - Hemophilia A | Recruiting | Emory University | 120 | 2020-03-17 | 2026-09-23 |
Hemophilia A (3) · Hematologic Diseases (1)
Octapharma (2) · Emory University (1)
Germany (3) · United States (3) · Finland (2) · France (2) · Italy (2) · Serbia (2) · Spain (2) · United Kingdom (2) · Croatia (1) · India (1) · North Macedonia (1) · Switzerland (1) · Uruguay (1)
Johannes Oldenburg (1) · Robert Sidonio, MD, MSc (1) · Shveta Gupta, MD (1)